Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Princess Private Equity Holding Limited LSE:PEY London Ordinary Share GG00B28C2R28 ORD EUR0.001 (EUR)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.10 0.77% 13.10 13.00 13.10 13.10 12.95 13.00 28,464 16:29:59
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 155.1 224.0 5.8 906

Princess Private Equity Share Discussion Threads

Showing 376 to 400 of 400 messages
Chat Pages: 16  15  14  13  12  11  10  9  8  7  6  5  Older
DateSubjectAuthorDiscuss
28/5/2021
07:40
Steady as she goes:- Guernsey, 28 May 2021 NAV increases by 1.5% in April -- Princess Private Equity Holding Limited's (Princess or the Company) net asset value increased by 1.5% to EUR 14.70 per share -- Portfolio developments (+1.7%) were positive while currency movements were flat -- Princess invested EUR 11.9 million during the month and received distributions of EUR 15.8 million Princess invested a total of EUR 11.9 million during April, of which EUR 9.5 million was invested in Wedgewood Pharmacy, a leading US animal-health compounding pharmacy business. Compounded medications are created and prepared by specialist pharmacists and pharmacy technicians when there is no commercially available alternative. Wedgewood holds over 66'000 relationships with veterinarians and directly serves more than 360'000 pet owners annually. Following the investment, Partners Group will work closely with Wedgewood's management team to implement new strategic initiatives that support ongoing organic growth. Key areas of focus will be investing in the Company's sales and marketing functions; enhancing technology to drive digital engagement with veterinarians and pet owners through multiple channels; and continuing its veterinary footprint expansion through corporate group partnerships and new customer acquisitions, as well as opportunistic M&A. EUR 2.3 million was deployed in a follow-on investment in eResearch Technology (ERT), a provider of integrated online software application services that enables the pharmaceutical, biotechnology and medical device industries to collect, interpret and distribute cardiac safety and clinical data more efficiently during clinical trials. The capital was used to fund the company's merger with US-based BioClinica, a provider of clinical trial imaging technology solutions to top pharmaceutical, biotechnology and medical device organizations. During the month Princess received distributions of EUR 15.8 million, of which EUR 13.2 million stemmed from a confidential private debt investment. The remaining balance of EUR 2.6 million was received predominantly from Princess' mature legacy fund portfolio.
cwa1
28/5/2021
07:40
Steady as she goes:- Guernsey, 28 May 2021 NAV increases by 1.5% in April -- Princess Private Equity Holding Limited's (Princess or the Company) net asset value increased by 1.5% to EUR 14.70 per share -- Portfolio developments (+1.7%) were positive while currency movements were flat -- Princess invested EUR 11.9 million during the month and received distributions of EUR 15.8 million Princess invested a total of EUR 11.9 million during April, of which EUR 9.5 million was invested in Wedgewood Pharmacy, a leading US animal-health compounding pharmacy business. Compounded medications are created and prepared by specialist pharmacists and pharmacy technicians when there is no commercially available alternative. Wedgewood holds over 66'000 relationships with veterinarians and directly serves more than 360'000 pet owners annually. Following the investment, Partners Group will work closely with Wedgewood's management team to implement new strategic initiatives that support ongoing organic growth. Key areas of focus will be investing in the Company's sales and marketing functions; enhancing technology to drive digital engagement with veterinarians and pet owners through multiple channels; and continuing its veterinary footprint expansion through corporate group partnerships and new customer acquisitions, as well as opportunistic M&A. EUR 2.3 million was deployed in a follow-on investment in eResearch Technology (ERT), a provider of integrated online software application services that enables the pharmaceutical, biotechnology and medical device industries to collect, interpret and distribute cardiac safety and clinical data more efficiently during clinical trials. The capital was used to fund the company's merger with US-based BioClinica, a provider of clinical trial imaging technology solutions to top pharmaceutical, biotechnology and medical device organizations. During the month Princess received distributions of EUR 15.8 million, of which EUR 13.2 million stemmed from a confidential private debt investment. The remaining balance of EUR 2.6 million was received predominantly from Princess' mature legacy fund portfolio.
cwa1
25/5/2021
17:05
Yes, strange dip bearing in mind the newsflow
stemis
25/5/2021
16:59
Decent couple of days share price wise
cwa1
24/5/2021
09:00
Nice Guernsey, 24 May 2021 Princess Private Equity to partially realize its investment in International School Partnership (ISP) Partners Group, the Investment Manager of Princess Private Equity Holding Limited ("Princess"), is expanding the shareholder base of International Schools Partnership ("ISP"), a leading international group of K-12 schools. Incoming shareholder OMERS, the defined benefit pension plan for municipal employees in the Province of Ontario, has agreed to acquire a 25% stake in ISP. Partners Group will continue to hold a majority stake in ISP on behalf of its clients. The transaction values ISP at an enterprise value of EUR 1.9 billion. The transaction values Princess' stake in ISP at approximately EUR 150 million. This compares to a carrying value of EUR 139 million at 31 March 2021. ISP was Princess' largest portfolio company at 31 March 2021, representing 13.9% of net assets. As part of the transaction Princess will reduce its exposure to ISP but will retain an investment of approximately EUR 20 million to continue to participate in the future growth of the business.
cwa1
19/5/2021
07:21
Presentation... https://www.princess-privateequity.net/fileadmin/PG_Princess/documents/Presentations/Conf_Call_Presentation/Princess_conf_call_Q1_2021_vF.pdf
cwa1
17/5/2021
13:14
Discount of approx. 16%, dividend yield of 5.5% and likely to increase next year , these seem like great value at the moment.
whilstev
15/5/2021
17:20
Worth mentioning it went ex-dividend on Thursday to account for a small proportion of that
cwa1
15/5/2021
15:16
A quick spike to 13.20; now back down to 11.80 - Currency headwind perhaps.
skyship
29/4/2021
09:42
Wow NAV up 7.3% to 14.49 Euros no wonder the share price has hit new highs recently.
whilstev
18/4/2021
12:27
See the PE thread for a good FT article on the sector...
skyship
15/4/2021
21:51
Yes, brilliant rise of 15.5% on annual dividend. Very welcome increase.
bluemango
15/4/2021
10:01
Excellent increase in div to 33.5 Euro cents so full year div should be 67 cents.
whilstev
01/4/2021
12:05
52 week high
bluemango
31/3/2021
13:01
Also significant boost to NAV and therefore future dividends.
whilstev
31/3/2021
12:48
Good stuff, happy with those
cwa1
31/3/2021
11:50
Looks like two decent exits, giving PEY significant cash to re-employ.
bluemango
24/3/2021
10:24
NAV EUR 13.50.
whilstev
17/2/2021
12:38
Assume that quarterly investors Conference call was well received yesterday.
bluemango
28/1/2021
13:15
NAV now EUR 13.35.
whilstev
31/12/2020
11:59
Approaching its all-time high reached in early 2020.
bluemango
23/12/2020
07:13
Princess Private Equity Holding Ltd 23 December 2020 News Release Guernsey, 23 December 2020 NAV increases by 3.1% in November -- Princess Private Equity Holding Limited's (Princess or the Company) net asset value increased by 3.1% to EUR 12.96 per share -- Portfolio developments were positive (+3.5%) and currency movements were negative (-0.2%) -- Princess invested EUR 2.0 million during the month and received distributions of EUR 2.0 million In November, Princess' NAV increased by 3.1%. Valuation increases were underpinned by positive news around the development of COVID-19 vaccines and a general positive market sentiment. Amongst the largest contributors to performance was GlobalLogic. The company provides outsourced software product engineering services for businesses globally, supporting clients' digital transformation and strengthening their digital capabilities, products, and end-customer experiences. During November, GlobalLogic acquired ECS Group, a London-based cloud digital solutions provider with a focus on digital engineering, data analytics, and customer experience. ECS strengthens GlobalLogic's footprint in the U.K. and expands the company's financial services customer base and capabilities.
cwa1
10/12/2020
14:52
Edison research(may require free registration):- https://www.edisongroup.com/wp-content/uploads/2020/12/Princess-Private-Equity-Holding-Resilient-portfolio-continues-to-expand.pdf Princess Private Equity Holding (PEY) recorded a solid 10.0% NAV total return over the 12-month period ending on 30 October 2020, despite a 14.1% decline in March reflecting the initial impact of COVID-19. Its welldiversified portfolio, focused on relatively resilient sectors, required minor additional financing to mitigate liquidity risks. The rate of new investment picked up in Q320 and reached €63.5m ytd, close to the FY19 total of €69.3m. As there is currently no material portfolio funding requirement according to the investment manager, PEY reinstated its dividend policy and decided to pay a second interim dividend on par with the H219 distribution.
cwa1
26/11/2020
13:33
XD today with pay day on 7/1/21
cwa1
25/11/2020
15:44
Pleasantly perky
cwa1
Chat Pages: 16  15  14  13  12  11  10  9  8  7  6  5  Older
ADVFN Advertorial
Your Recent History
LSE
PEY
Princess P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210612 15:24:39